Creative Medical Technology Holdings (CELZ) EBT (2010 - 2026)

Creative Medical Technology Holdings (CELZ) has reported EBT for 17 consecutive years, with -$1.5 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBT fell 22.54% year-over-year to -$1.5 million in Q2 2026; TTM through Jun 2026 was -$6.0 million, a 4.73% decrease from a year earlier, with the FY2025 full-year figure at -$6.0 million, down 9.13% from the prior year.
• EBT was -$1.5 million for Q2 2026 at Creative Medical Technology Holdings, down from -$1.4 million in the prior quarter.
• Over five years, EBT peaked at -$982339.0 in Q3 2022 and troughed at -$6.2 million in Q4 2022.
• A 5-year average of -$1.7 million and a median of -$1.4 million in 2023 frame the typical range for EBT.
• Across the five-year window, EBT slumped 104.15% in 2022 and soared 72.99% in 2023, its largest moves.
• Over 5 years, EBT stood at -$6.2 million in 2022, then soared by 72.99% to -$1.7 million in 2023, then fell by 10.46% to -$1.9 million in 2024, then declined by 1.81% to -$1.9 million in 2025, then rose by 19.94% to -$1.5 million in 2026.
• The last three EBT figures came in at -$1.5 million (Q2 2026), -$1.4 million (Q1 2026), and -$1.9 million (Q4 2025), per Business Quant data.